GlassScriptPhysician profile
Stefano Themio Mitsakis
NPI 1942031265
$4,932.02
in general payments reported to CMS, 2019-2025
15 companies · $2,738 in 2025
The $2,738 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,194 · 2025: $2,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759 · Travel and Lodging: $2,119 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.17 |
| Travel and Lodging | $2,118.85 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,909.12 | 2024-2025 | Synchromedii, Inceptiv |
| Curonix LLC | $1,186.89 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $331.39 | 2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $189.39 | 2025 | Belbuca |
| Tersera Therapeutics LLC | $187.36 | 2024-2025 | Prialt |
| Biotronik Nro, INC. | $182.94 | 2025 | Prospera |
| Globus Medical, INC. | $178.21 | 2025 | Senza |
| Abbott Laboratories | $172.86 | 2024-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $151.81 | 2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.84 | 2025 | Relistor |
| Saluda Medical Americas, INC. | $111.10 | 2025 | Evoke |
| Protega Pharmaceutials INC | $83.95 | 2024-2025 | Roxybond |
| Abbvie INC. | $65.93 | 2024-2025 | |
| Convatec INC. | $19.17 | 2025 | |
| Scilex Pharmaceuticals INC. | $19.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefano Mitsakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.